Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 AzurRx BioPharmaOncolytics BiotechOncomed PharmaceuticalsVIVUSAkari Therapeutics
SymbolNASDAQ:AZRXNASDAQ:ONCYNASDAQ:OMEDNASDAQ:VVUSNASDAQ:AKTX
Price Information
Current Price$1.09$1.62$0.89$3.39$1.85
52 Week RangeBuyBuyHoldN/ABuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldN/ABuy
Consensus Price Target$7.5833N/A$1.75N/A$7.00
% Upside from Price Target595.72% upsideN/A96.63% upsideN/A278.38% upside
Trade Information
Market Cap$23.80 million$32.07 million$34.43 million$35.86 million$29.34 million
Beta2.242.041.861.86-2.75
Average Volume109,06033,035768,90490,966137,838
Sales & Book Value
Annual RevenueN/AN/A$44.42 million$65.06 millionN/A
Price / SalesN/AN/A0.780.55N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.26 per share$0.27 per share$1.25 per share($3.77) per share$0.20 per share
Price / BookN/AN/A0.71-0.90N/A
Profitability
Net Income$-13,530,000.00$-13,140,000.00$-8,100,000.00$-36,950,000.00$-16,470,000.00
EPS($0.88)($0.82)($0.16)($3.48)($0.17)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-18.24%-49.41%N/A
Return on Equity (ROE)-286.41%-217.52%-13.14%N/A-369.81%
Return on Assets (ROA)-158.60%-99.02%-7.73%-11.38%-152.87%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.07%N/AN/AN/A
Current Ratio0.49%3.39%5.04%4.05%1.13%
Quick Ratio0.49%3.39%5.04%3.48%1.13%
Ownership Information
Institutional Ownership Percentage13.12%0.97%45.16%15.61%14.90%
Insider Ownership Percentage7.20%0.10%20.32%12.00%61.80%
Miscellaneous
Employees12N/A225717
Shares Outstanding21.06 million20.30 million38.69 million10.64 million15.86 million
Next Earnings Date8/9/2019 (Estimated)8/2/2019 (Estimated)N/A8/6/2019 (Estimated)8/16/2019 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableNot Optionable
 AzurRx BioPharmaOncolytics BiotechOncomed PharmaceuticalsVIVUSAkari Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel